BMY — Bristol Myers Squibb

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus ...

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Industry

PHARMACEUTICAL PREPARATIONS

Sector

Healthcare

Exchange

NYSE

First trade date

1952-06-23

The interactive platform loads with JavaScript. Research tools are for informational purposes.